Drug research2022,Vol.72Issue(4) :9.DOI:10.1055/a-1713-3137

In silico Investigation of Lon Protease as a Promising Therapeutic Target

Parisa Asadollahi Iraj Pakzad Sobhan Ghafourian Hossein Kazemian Roohollah Fatahi Nourkhoda Sadeghifard Behrooz Sadeghi Kalani
Drug research2022,Vol.72Issue(4) :9.DOI:10.1055/a-1713-3137

In silico Investigation of Lon Protease as a Promising Therapeutic Target

Parisa Asadollahi 1Iraj Pakzad 1Sobhan Ghafourian 1Hossein Kazemian 1Roohollah Fatahi 2Nourkhoda Sadeghifard 3Behrooz Sadeghi Kalani1
扫码查看

作者信息

  • 1. Department of Microbiology, Faculty of Medicine, Ilam University of Medical Sciences, Ilam
  • 2. Faculty of Para Veterinary Medicine, Ilam University,Ilam.Iran
  • 3. Clinical Microbiology Research Center, Ilam University of Medical Sciences, Ilam
  • 折叠

Abstract

Considering the widespread occurrence of antibiotic resistance, the need for new therapeutic strategies is inevitable. Bacterial proteases are a broad set of enzymes that play a vital role in cell survival, stress response, and pathogenicity. This in silico study was aimed to focus on the crucial role of Lon protease in the regulation of toxin-antitoxin systems in E. coli and to design inhibitory peptides against the action of this protease. With the help of relevant servers and softwares, the communication network, the evolutionary history, and the interaction of Lon with the corresponding antitoxins were examined, following which the inhibitory peptides were designed against these interactions. The results showed that Lon protease plays a central role in the control of these systems and is a conserved protein, especially among the Enterobacteriaceae family. The docking results of the designed peptides with the Lon protease were significant. This study showed that Lon protease may have the characteristics of a new therapeutic target.

Key words

in silico/Lon protease/E. coli/Antitoxin/inhibitory peptides

引用本文复制引用

出版年

2022
Drug research

Drug research

ESCI
ISSN:2194-9379
被引量1
参考文献量29
段落导航相关论文